The All-Party Parliamentary Group on Liver Disease and Liver Cancer sets ambitious agenda for the year ahead
The All-Party Parliamentary Group (APPG) on Liver Disease and Liver Cancer met for its Annual General Meeting (AGM) to reflect on a highly impactful first year and to set priorities for ensuring liver disease and liver cancer remain firmly on the parliamentary agenda....
Love Your Liver roadshow visits Stormont Assembly in Northern Ireland
In September, we brought our Love Your Liver roadshow to Stormont, the seat of Northern Ireland’s Assembly, to highlight the importance of prevention, early detection and action on liver disease. The event was an invaluable opportunity to meet with Members of the...
New publication tackling stigma in liver disease
The British Liver Trust has teamed up with leading liver doctors to create an important new article on the causes and impact of stigma, and how we can tackle it. The commentary article came out this week in Frontline Gastroenterology which is part of the British...
British Liver Trust welcomes SMCs decision to approve Elafibranor for use in NHS Scotland
The Scottish Medicines Consortium (SMC) has today recommended elafibranor as a second-line treatment for primary biliary cholangitis (PBC). This is the first new PBC drug accepted by the SMC in nearly a decade, offering an additional treatment option for people living...